Ongoing research studies are discovering that early use of hormone replacement therapy (HRT) can help delay the onset of ...

During a live event, Heather L. McArthur, MD, MPH, discussed the TAILORx trial in node-negative hormone ...

A novel oral peptide PN-477o with once-daily dosing, high potency and activation of glucagon-like peptide-1 (GLP-1), ...

The Business Research Company The Business Research Company's Estrogen Receptor Modulators Global Market Report 2025 – Market Size, Trends, ...

Panelists discuss the expanding array of treatment options for metastatic hormone receptor–positive breast cancer, ...

Hormone receptors articles from across Nature Portfolio Binding of hormone to a hormone receptor can initiate a cell signalling cascade or promote changes in gene transcription. Depending on the ...

See why the ovary − often reduced to its reproductive role − menopause, age and estrogen affect a woman’s health throughout ...

A hormone produced in the gut, FGF19, has been shown to act directly on the brain to boost energy expenditure, burn fat and ...

Ensem Therapeutics doses first patient in phase 1/2 clinical study of ETX-636, a novel allosteric pan-mutant-selective PI3Ka inhibitor and degrader: Waltham, Massachusetts Saturda ...

Glucagon-like peptide 1 receptor (GLP-1R) agonism is a validated approach for treating obesity. ECC-4703 is a small molecule and liver-targeting compound developed by Eccogene Co. Ltd. It is an ...

Hormone therapy may be used by young women to relieve symptoms from hormone-­related conditions, menopause, or gynecologic surgery. Long-term use of estrogen/progestin hormone therapy was positively ...

Breast cancer incidence trends differ by age, even among older women, particularly by race and ethnicity and stage at ...